Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06648278 · ClinicalTrials.gov registry record · NA
Patient Care Outreach, Navigation, Technology and Support 2.0
A NA study of Breast Cancer and Cardiovascular Diseases, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 260
- Enrollment target
- 2
- Study locations
NCT06648278: Recruiting NA study of Breast Cancer and Cardiovascular Diseases, sponsored by University of California, San Francisco.
NCT06648278 is a NA study of Breast Cancer and Cardiovascular Diseases that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 260 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06648278, a NA study of Breast Cancer and Cardiovascular Diseases, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 260 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a feasibility study employing virtual patient navigation for underserved individuals who speak English, Chinese or Spanish and were diagnosed with breast cancer or cardiovascular disease to determine the extent of usability for a virtual patient navigation portal serving people in underserved communities. While not able to entirely replace in-person interactions, virtual patient navigation may be used to expand reach and availability of navigation services to a much greater segment of the population.
Conditions Studied
Interventions
- OTHER Survey Administration
- BEHAVIORAL Patient Navigation Program
- OTHER Quality-of-Life (QOL) Assessment
Study Locations (2)
California
- Zuckerberg San Francisco General Hospital - San Francisco
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2023-08-10 |
| Est. Completion | 2027-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06648278
The ClinicalTrials.gov registry entry for NCT06648278 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (91% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 3 interventions - of which Survey Administration is the first listed.
NCT06648278 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06648278 about?
NCT06648278 is a clinical study titled "Patient Care Outreach, Navigation, Technology and Support 2.0". This is a feasibility study employing virtual patient navigation for underserved individuals who speak English, Chinese or Spanish and were diagnosed with breast cancer or cardiovascular disease to determine the extent of usability for a virtual patient navigation portal serving people in underserve...
What is the current status of trial NCT06648278?
This trial is currently recruiting. It is a NA study. The enrollment target is 260 participants. The study started on 2023-08-10. Estimated completion is 2027-02-28.
What conditions does trial NCT06648278 study?
This clinical trial studies the following conditions: Breast Cancer, Cardiovascular Diseases.
What interventions are being tested in trial NCT06648278?
The interventions under investigation include: Survey Administration (OTHER), Patient Navigation Program (BEHAVIORAL), Quality-of-Life (QOL) Assessment (OTHER).
Who is sponsoring clinical trial NCT06648278?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06648278 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.